Targeted Relief with Diclofenac Sodium
Voltarol Suppositories contain diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, swelling and inflammation. Available in 12.5mg, 25mg, 50mg and 100mg strengths, Voltarol suppositories provide a rectal formulation for patients who have been prescribed diclofenac in this form.
Diclofenac sodium works as an anti-inflammatory medicine and is used for a range of painful conditions affecting the joints, muscles and tendons, including rheumatoid arthritis, osteoarthritis, acute gout, back pain, sprains, strains, tendonitis and bursitis. It may also be prescribed for pain associated with dental or minor surgery.
Convenient Suppository Form
For patients prescribed this formulation, Voltarol suppositories offer an alternative route of administration to oral diclofenac. The suppositories are designed for rectal use only and must not be taken by mouth. The appropriate strength and dosage depend on the individual’s condition and medical advice.
The available strengths—12.5mg, 25mg, 50mg and 100mg—allow healthcare professionals to select an appropriate treatment regimen according to the patient’s needs.
Important Information Before Use
Voltarol suppositories are prescription-only medicines in the UK. They should be used exactly as directed by a doctor or pharmacist, with the lowest effective dose used for the shortest necessary duration.
Diclofenac is not suitable for everyone and can interact with other medicines. Patients should read the accompanying patient information leaflet carefully and speak with their doctor or pharmacist if they have questions about suitability, dosage, interactions or possible side effects.
Active ingredient: Diclofenac sodium
Medicine type: NSAID
Form: Rectal suppository
Strengths: 12.5mg, 25mg, 50mg and 100mg
Route: Rectal administration only
UK status: Prescription only medicine
Always follow your prescriber’s instructions and the official patient information leaflet supplied with the medicine.




Reviews
There are no reviews yet.